Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled date : 2021 - 09 - 07 save search
Aditxt Announces Closing of $11 Million Registered Direct Offering, and Funding of Bridge Loan Satisfying a Key Term of its Letter of Intent for Planned Acquisition of Commercial Stage Pharma Company with Anti-Viral COVID-19 Therapy
Published: 2021-09-07 (Crawled : 17:00) - biospace.com/
ADTX | $2.37 0.85% 0.84% 55K
|
Health Technology
|
| O: 2.26%
H: 1.66%
C: -1.66%
covid offering funding acquisition therapy antiviral
Neuronetics and Zion Healing Announce First Franchise Model for TMS ClinicsIndustry-changing partnership will increase patient access to NeuroStar® Advanced Therapy for Mental Health
Published: 2021-09-07 (Crawled : 14:00) - biospace.com/
STIM | $3.82 -3.54% -3.66% 85K
|
Health Technology
|
| O: -0.66%
H: 2.13%
C: -2.4%
partnership therapy
Citius Pharmaceuticals Acquires Dr. Reddy's Laboratories' License for Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indications
Published: 2021-09-07 (Crawled : 12:15) - biospace.com/
RDY | $70.91 -0.56% 0.0% 97K
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: -0.48%
CTXR | $0.8 -1.99% -2.02% 6.3M
|
Health Technology
|
| O: 3.37%
H: 5.93%
C: -1.4%
treatment immunotherapy therapy cancer license phase 3 t-cell e7777
Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies
Published: 2021-09-07 (Crawled : 12:00) - biospace.com/
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: 23.48%
H: 11.8%
C: 4.43%
collaboration cancer research t-cell commercialization therapy
Merck’s KEYTRUDA® (pembrolizumab) Approved in China in Combination With Chemotherapy for First-Line Treatment of Patients With Locally Advanced Unresectable or Metastatic Esophageal or Gastroesophageal Junction (GEJ) Carcinoma
Published: 2021-09-07 (Crawled : 12:00) - biospace.com/
MRK | $125.23 -0.11% 0.0% 6M
|
Health Technology
|
| O: -0.85%
H: 0.37%
C: -0.8%
treatment china therapy keytruda
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.